Read about the Oxford Vaccine Centre’s COVID-19 vaccine trial.
Com-COV3: Vaccine study to research third dose booster options for 12-to-15 year-olds –find your closest study site and read the press release
Recruiting Now: Help us investigate the first ever vaccine for Invasive Non-Typhoid Salmonella (iNTS) – The SALVO Trial
If you are aged 18 to 55 years old, in good health and live in the Oxford area, then you may be eligible to take part.
Take part in a clinical trial – see a list of all the trials we are currently recruiting to.
Non-COVID research statement
The Oxford Vaccine Group will be continuing with some of our non-COVID research, particularly our paediatric studies, during the COVID-19 pandemic. This is because as part of these studies we give babies their routine primary immunisations on behalf of their GPs. This reduces the administrative burden on the NHS, allowing them to free up capacity and prioritise their workload to be focused on doing what is necessary to manage the response to the COVID-19 pandemic. The participants also benefit from having the vaccines in the safety of their homes or a convenient location.
Research
Vaccines are a key component of global health policy and are essential in the defence of the health of young children. Our research focuses on the development and evaluation of new and improved vaccines.
Events and Training
We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.
Get involved
There are a number of ways in which you can get involved in our research, inform our research and find out more about our work. To find out more about any of these options, follow the link below.
Latest publications
-
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial
Journal article
MAIDEN M. et al, (2022), Vaccine
-
Osteoarticular Infections in Pediatric Hospitals in Europe: A Prospective Cohort Study From the EUCLIDS Consortium
Journal article
Trobisch A. et al, (2022), Frontiers in Pediatrics, 10
-
Prevention of typhoid by Vi conjugate vaccine and achievable improvements in household WASH: Evidence from a cluster-randomized trial in Dhaka, Bangladesh.
Journal article
Tadesse BT. et al, (2022), Clin Infect Dis
-
Non-Tuberculous Mycobacterial Infection of the Retropharyngeal Space.
Journal article
Weng A. et al, (2022), Pediatr Infect Dis J
-
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial.
Journal article
Liu X. et al, (2022), J Infect
Upcoming events
IIC 2022 - Hot Topics In Infection And Immunity In Children
Thursday, 30 June 2022 to Saturday, 02 July 2022
IIC – The ESPID-Oxford Course is a residential training course covering topics in paediatric infection for paediatric infectious diseases trainees and trainers, and for all those who manage children with infections. This will be the 19th edition of the course.